The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Measuring Alpha-Synuclein in Extracellular Vesicles, 2025Measurement of Alpha-synuclein in Plasma Extracellular Vesicles after Automated Isolation
Study Rationale: Extracellular vesicles are small, membrane-enclosed packages that all cells release into the blood. Because the contents of these packages reflect that of the cells from which they...
-
iPSC Phenotyping Environmental Exposure Program, 2024Use of a Stem-cell-based Platform to Screen for Environmental Factors in Parkinson’s Disease
Study Rationale: Both environmental and genetic factors are believed to be involved in Parkinson’s disease (PD). Although the genetic mutations linked to PD have been studied intensively, it is...
-
iPSC Phenotyping Environmental Exposure Program, 2024Establishing a Proof-of-concept, Automated Platform for Studying the Interactions of Genetic and Environment-based Toxicity in Human Cell Models of Parkinson’s Disease
Study Rationale: Many studies of Parkinson’s disease (PD) focus on investigating the disease’s genetic component. Yet only about 22% of PD diagnoses carry a genetic association. Increasing evidence...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025Validating Hallmarks of Inflammation in a Preclinical Alpha-synuclein Model of Parkinson’s Disease
Study Rationale: Inflammation and abnormal protein clumps in the brain are strongly associated with Parkinson's disease (PD). To study the mechanism of inflammation and disease progression related to...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2025(SUPPLEMENT) Discovery of Translational Biomarkers for Endolysosomal Pathway Pathology Using Lipidomics and Metabolomics
Study Rationale: The endolysosomal system in living cells is comprised of small, specialized structures that contain enzymes that degrade proteins and remove molecular waste. Impaired function of this...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2025GBA1 Consortium: Joint Analysis to Inform Clinical Trials
Study Rationale: Variants in the GB1A gene represent the most important genetic risk factor for Parkinson’s disease (PD) across the globe. However, different GBA1 variants are associated with varied...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.